Rationale bedaquiline and rifampicin combination
Bedaquiline, the first new drug to be developed against The bioavailability of bedaquiline increases with food (a 2-fold increase in AUC, see label). The exposure of rifampicin, when administered with food, decreases slightly but this is not considered clinically relevant. Therefore, we will offer a snack when PEP is administered.